Tirschwell & Loewy’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$520K Hold
10,900
0.07% 56
2018
Q4
$567K Hold
10,900
0.09% 55
2018
Q3
$677K Hold
10,900
0.08% 53
2018
Q2
$603K Buy
10,900
+1,000
+10% +$54K 0.08% 60
2018
Q1
$626K Hold
9,900
0.09% 62
2017
Q4
$607K Hold
9,900
0.09% 65
2017
Q3
$631K Hold
9,900
0.1% 65
2017
Q2
$552K Hold
9,900
0.09% 69
2017
Q1
$538K Hold
9,900
0.09% 68
2016
Q4
$579K Hold
9,900
0.1% 67
2016
Q3
$534K Hold
9,900
0.09% 69
2016
Q2
$728K Hold
9,900
0.13% 65
2016
Q1
$632K Hold
9,900
0.11% 67
2015
Q4
$681K Hold
9,900
0.12% 67
2015
Q3
$586K Hold
9,900
0.11% 66
2015
Q2
$659K Sell
9,900
-600
-6% -$39.5K 0.11% 67
2015
Q1
$677K Sell
10,500
-100
-0.9% -$6.26K 0.11% 67
2014
Q4
$626K Hold
10,600
0.1% 67
2014
Q3
$543K Hold
10,600
0.09% 67
2014
Q2
$514K Hold
10,600
0.08% 67
2014
Q1
$551K Sell
10,600
-1,900
-15% -$101K 0.09% 69
2013
Q4
$664K Hold
12,500
0.12% 68
2013
Q3
$579K Hold
12,500
0.11% 68
2013
Q2
$559K Buy
+12,500
New +$543K 0.12% 70

Other funds holding BMY

Tirschwell & Loewy's BMY Position: Q1 2019 in Review

Tirschwell & Loewy held its Bristol-Myers Squibb (BMY) position steady in Q1 2019 at 10,900 shares worth $520K. The position accounts for 0.07% of the portfolio, ranked #56.

Tirschwell & Loewy first reported a position in BMY in Q2 2013 and has held it in 24 quarters since. The position peaked at $728K in Q2 2016. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Tirschwell & Loewy held 10,900 shares of Bristol-Myers Squibb worth $520K as of Q1 2019.
  • Tirschwell & Loewy left its Bristol-Myers Squibb share count unchanged in Q1 2019.
  • Bristol-Myers Squibb made up 0.07% of Tirschwell & Loewy's portfolio in Q1 2019, its #56 holding.
  • Tirschwell & Loewy first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 24 quarters since.
  • Tirschwell & Loewy's Bristol-Myers Squibb position peaked at $728K in Q2 2016.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Tirschwell & Loewy's 13F filing for Q1 2019, filed 3 Apr 2019.